The FDA is took its first big step toward deciding whether companies can add CBD to food, beverages and dietary supplements last week.
"Interest continues to skyrocket," said D.C. attorney Miriam Guggenheim, co-chair of the food, drug and device practice group at Covington & Burling. "It is mainstream, interest is mainstream. It is not fringe anymore, which doesn't mean mainstream companies are ready to jump in. But they want to be prepared to do so once the legal landscape is clarified."
David Spangler, senior vice president of policy and general counsel of the Consumer Healthcare Products Association, said he hasn't seen so much interest in an issue he's worked on since 2007 when pediatricians urged the FDA to ban cold and cough medicines for children under age 6. The FDA, which is taking public comments on how to regulate the industry through July 2, has some 140 people scheduled to testify Friday. Drafting and implementing a rule could take years, officials have said.
"I think a lot of people are holding out what I consider somewhat false hope that we'll come out of this hearing with all the answers to our burning questions," said Jonathan Havens, co-chair of the cannabis law practice at Saul Ewing Arnstein & Lehr.formed a working group in April to evaluate how to regulate CBD.
The agency has focused its CBD enforcement on companies that make "egregious" claims, like using it to treat Alzheimer's, cancer and other diseases it's not approved for. It issued
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Lilly's migraine drug as first ever cluster headache treatmentEli Lilly and Co's migraine treatment Emgality on Tuesday became the first ...
Read more »
FDA approves Lilly's migraine drug as first ever cluster headache treatmentThe drug will be priced the same as for migraine on a per milligram basis, but the cost will vary depending on the length of treatment. Emgality for migraines costs $6,900 a year.
Read more »
FDA approves Lilly's migraine drug as first cluster headache treatmentClinical trials showed that a one-month injection of Emgality, a migraine drug, significantly reduced the frequency of cluster headaches.
Read more »
FDA tests highlight rising concerns about potentially harmful chemicals in foodGovernment tests have found high levels of potentially harmful chemicals used in nonstick surfaces and firefighting foams in foods that are produced near contaminated sites, FDA says.
Read more »
FDA Notches Court Win in Case Over Stem-Cell ClinicUS Stem Cell Clinic didn’t follow proper procedures for handling stem cells used to treat illnesses, a federal judge ruled Monday
Read more »
FDA wins case against Florida stem cell clinic that blinded three womenThe FDA has won a federal judge's backing for its efforts to crack down on the rapidly growing stem cell industry that promises all kinds of unproven treatments for serious diseases.
Read more »